Inari Medical to Announce Fourth Quarter and Full Year 2023 Financial Results
14 Février 2024 - 10:05PM
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device
company with a mission to treat and transform the lives of patients
suffering from venous and other diseases, today announced that it
will release its fourth quarter and full year 2023 financial
results on Wednesday, February 28, 2024. In conjunction with the
release, Inari will host a conference call and webcast at 1:30 p.m.
Pacific Time / 4:30 p.m. Eastern Time to discuss its financial
results and recent highlights.
Interested parties may access the live call via telephone by
dialing 844-825-9789 for domestic callers or 412-317-5180 for
international callers. The live webinar may be accessed by visiting
the Events Section of the Inari investor relations website or by
registering here. A replay of the webinar will be available shortly
after the conclusion of the call and will be archived on Inari’s
website.
About Inari Medical, Inc.Patients first. No
small plans. Take care of each other. These are the guiding
principles that form the ethos of Inari Medical. We are committed
to improving lives in extraordinary ways by creating innovative
solutions for both unmet and underrecognized health needs. In
addition to our purpose-built products, we leverage our
capabilities in education, clinical research, and program
development to improve patient outcomes. We are passionate about
our mission to establish our treatments as the standard of care for
venous thromboembolism and beyond. We are just getting started.
Investor Contact:
John Hsu, CFAVP, Investor
Relations949-658-3889IR@inarimedical.com
Inari Medical (NASDAQ:NARI)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Inari Medical (NASDAQ:NARI)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024